Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.69M | 10.48M | 10.19M | 10.14M | 9.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.69M | 10.48M | 10.19M | 10.14M | 9.76M |
| Cost of Revenue | 1.96M | 2.09M | 2.06M | 2.12M | 2.04M |
| Gross Profit | 9.73M | 8.40M | 8.13M | 8.02M | 7.72M |
| SG&A Expenses | 24.02M | 22.78M | 22.00M | 22.18M | 23.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.52M | 40.34M | 41.57M | 42.43M | 43.68M |
| Operating Income | -30.83M | -29.86M | -31.39M | -32.29M | -33.92M |
| Income Before Tax | -39.25M | -38.33M | -36.21M | -38.87M | -41.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.25 | -38.33 | -36.21 | -38.87 | -41.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 759.00K | 584.00K | 543.00K | 548.00K | 601.00K |
| Net Income | -38.49M | -37.74M | -35.67M | -38.32M | -41.30M |
| EBIT | -30.83M | -29.86M | -31.39M | -32.29M | -33.92M |
| EBITDA | -28.93M | -27.94M | -29.43M | -30.28M | -31.91M |
| EPS Basic | -235.25 | -495.84 | -1.03K | -1.96K | -1.88K |
| Normalized Basic EPS | -152.92 | -307.32 | -806.36 | -1.39K | -1.32K |
| EPS Diluted | -238.12 | -498.72 | -1.03K | -1.97K | -1.88K |
| Normalized Diluted EPS | -152.92 | -307.32 | -806.36 | -1.39K | -1.32K |
| Average Basic Shares Outstanding | 1.05M | 607.30K | 246.30K | 164.10K | 58.20K |
| Average Diluted Shares Outstanding | 1.05M | 607.30K | 246.30K | 164.10K | 58.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |